144 related articles for article (PubMed ID: 30817615)
1. Circulating uPA as a potential prognostic biomarker for resectable esophageal squamous cell carcinoma.
He X; Xu X; Zhu G; Ye H
Medicine (Baltimore); 2019 Mar; 98(9):e14717. PubMed ID: 30817615
[TBL] [Abstract][Full Text] [Related]
2. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
[TBL] [Abstract][Full Text] [Related]
3. Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K/AKT and ERK signaling in esophageal squamous cell carcinoma.
Tian B; Chen X; Zhang H; Li X; Wang J; Han W; Zhang LY; Fu L; Li Y; Nie C; Zhao Y; Tan X; Wang H; Guan XY; Hong A
Oncotarget; 2017 Jun; 8(26):42300-42313. PubMed ID: 28404945
[TBL] [Abstract][Full Text] [Related]
4. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
Wang WT; Guo CQ; Cui GH; Zhao S
World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
[TBL] [Abstract][Full Text] [Related]
5. microRNA-195-Cdc42 axis acts as a prognostic factor of esophageal squamous cell carcinoma.
Sun N; Ye L; Chang T; Li X; Li X
Int J Clin Exp Pathol; 2014; 7(10):6871-9. PubMed ID: 25400770
[TBL] [Abstract][Full Text] [Related]
6. Role of urokinase plasminogen activator and its receptor in metastasis and invasion of neuroblastoma.
Li P; Gao Y; Ji Z; Zhang X; Xu Q; Li G; Guo Z; Zheng B; Guo X
J Pediatr Surg; 2004 Oct; 39(10):1512-9. PubMed ID: 15486896
[TBL] [Abstract][Full Text] [Related]
7. [Expression of cytokeratin(CK)7, CK8/18, CK19 and p40 in esophageal squamous cell carcinoma and their correlation with prognosis].
Yang ZY; Zhang HY; Wang F; Ma YH; Li YY; He HL; Wang C; Li SS
Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):834-839. PubMed ID: 30423606
[No Abstract] [Full Text] [Related]
8. Prognostic values of STAT3 and HIF-1α in esophageal squamous cell carcinoma.
Zhao X; Tang YP; Wang CY; Wu JX; Ye F
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3351-3357. PubMed ID: 31081089
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of urokinase-type plasminogen activator expression in squamous cell carcinomas of the esophagus.
Torzewski M; Sarbia M; Verreet P; Dutkowski P; Heep H; Willers R; Gabbert HE
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2263-8. PubMed ID: 9815623
[TBL] [Abstract][Full Text] [Related]
10. Increased MET gene copy number negatively affects the survival of esophageal squamous cell carcinoma patients.
Wang Y; Jiang Z; Xu C; Wang H; Tan L; Su J; Wang X; Jiang D; Hou Y; Song Q
BMC Cancer; 2019 Mar; 19(1):240. PubMed ID: 30885149
[TBL] [Abstract][Full Text] [Related]
11. CK19 mRNA expression in the bone marrow of patients with esophageal squamous cell carcinoma and its clinical significance.
Zhang X; Chen SB; Chen JX; Wen J; Yang H; Xie MR; Zhang Y; Hu YZ; Lin P
Dis Esophagus; 2010 Jul; 23(5):437-43. PubMed ID: 20095997
[TBL] [Abstract][Full Text] [Related]
12. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y
Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of red cell distribution width in esophageal squamous cell carcinoma.
Hirahara N; Tajima Y; Fujii Y; Hyakudomi R; Yamamoto T; Ishitobi K; Taniura T; Kawabata Y
J Surg Res; 2018 Oct; 230():53-60. PubMed ID: 30100040
[TBL] [Abstract][Full Text] [Related]
14. Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma.
Yang Y; Huang X; Zhou L; Deng T; Ning T; Liu R; Zhang L; Bai M; Zhang H; Li H; Ba Y
BMC Cancer; 2019 May; 19(1):526. PubMed ID: 31151431
[TBL] [Abstract][Full Text] [Related]
15. Prognostic implications of the co-detection of the urokinase plasminogen activator system and osteopontin in patients with non-small-cell lung cancer undergoing radiotherapy and correlation with gross tumor volume.
Ostheimer C; Evers C; Bache M; Reese T; Vordermark D
Strahlenther Onkol; 2018 Jun; 194(6):539-551. PubMed ID: 29340706
[TBL] [Abstract][Full Text] [Related]
16. Plasma microRNA-9 as a diagnostic and prognostic biomarker in patients with esophageal squamous cell carcinoma.
Cui Y; Xue Y; Dong S; Zhang P
J Int Med Res; 2017 Aug; 45(4):1310-1317. PubMed ID: 28587538
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of carcinoembryonic antigen-, cytokeratin 19-, or survivin-positive circulating tumor cells in the peripheral blood of esophageal squamous cell carcinoma patients treated with radiotherapy.
Yin XD; Yuan X; Xue JJ; Wang R; Zhang ZR; Tong JD
Dis Esophagus; 2012; 25(8):750-6. PubMed ID: 22394149
[TBL] [Abstract][Full Text] [Related]
18. Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.
Yoshizawa K; Nozaki S; Kitahara H; Kato K; Noguchi N; Kawashiri S; Yamamoto E
Oncol Rep; 2011 Dec; 26(6):1555-60. PubMed ID: 21833477
[TBL] [Abstract][Full Text] [Related]
19. High preoperative plasma fibrinogen and serum albumin score is associated with poor survival in operable esophageal squamous cell carcinoma.
Sun SY; Chen PP; Meng LX; Li L; Mo ZX; Sun CH; Wang Y; Liang FH
Dis Esophagus; 2019 Jan; 32(1):. PubMed ID: 29905761
[TBL] [Abstract][Full Text] [Related]
20. Expression and prognostic significance of long noncoding RNA AK001796 in esophageal squamous cell carcinoma.
Zong MZ; Shao Q; An XS
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):181-186. PubMed ID: 30657559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]